Pértega-Díaz Sonia, Balboa-Barreiro Vanesa, Seijo-Bestilleiro Rocío, González-Martín Cristina, Pardeiro-Pértega Remedios, Yáñez-González-Dopeso Loreto, García-Rodríguez Teresa, Seoane-Pillado Teresa
Research Support Unit, Nursing and Healthcare Research Group, Rheumatology and Health Research Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), As Xubias, Hotel de Pacientes 7ª Planta, 15006, A Coruña, Spain.
Digestive Apparatus Service, Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, As Xubias, 15006, A Coruña, Spain.
BMC Public Health. 2020 Nov 17;20(1):1738. doi: 10.1186/s12889-020-09807-x.
Improved colorectal cancer (CRC) survival rates have been reported over the last years, with more than half of these patients surviving more than 5 years after the initial diagnosis. Better understanding these so-called long-term survivors could be very useful to further improve their prognosis as well as to detect other problems that may cause a significant deterioration in their health-related quality of life (HRQoL). Cure models provide novel statistical tools to better estimate the long-term survival rate for cancer and to identify characteristics that are differentially associated with a short or long-term prognosis. The aim of this study will be to investigate the long-term prognosis of CRC patients, characterise long-term CRC survivors and their HRQoL, and demonstrate the utility of statistical cure models to analyse survival and other associated factors in these patients.
This is a single-centre, ambispective, observational follow-up study in a cohort of n = 1945 patients with CRC diagnosed between 2006 and 2013. A HRQoL sub-study will be performed in the survivors of a subset of n = 485 CRC patients for which baseline HRQoL data from the time of their diagnosis is already available. Information obtained from interviews and the clinical records for each patient in the cohort is already available in a computerised database from previous studies. This data includes sociodemographic characteristics, family history of cancer, comorbidities, perceived symptoms, tumour characteristics at diagnosis, type of treatment, and diagnosis and treatment delay intervals. For the follow-up, information regarding local recurrences, development of metastases, new tumours, and mortality will be updated using hospital records. The HRQoL for long-term survivors will be assessed with the EORTC QLQ-C30 and QLQ-CR29 questionnaires. An analysis of global and specific survival (competitive risk models) will be performed. Relative survival will be estimated and mixture cure models will be applied. Finally, HRQoL will be analysed through multivariate regression models.
We expect the results from this study to help us to more accurately determine the long-term survival of CRC, identify the needs and clinical situation of long-term CRC survivors, and could be used to propose new models of care for the follow-up of CRC patients.
过去几年有报道称结直肠癌(CRC)患者的生存率有所提高,超过半数患者在初次诊断后存活超过5年。更好地了解这些所谓的长期存活者对于进一步改善其预后以及发现可能导致其健康相关生活质量(HRQoL)显著恶化的其他问题可能非常有用。治愈模型提供了新的统计工具,以更好地估计癌症的长期生存率,并识别与短期或长期预后有差异关联的特征。本研究的目的是调查CRC患者的长期预后,描述长期CRC存活者及其HRQoL,并证明统计治愈模型在分析这些患者的生存及其他相关因素方面的实用性。
这是一项针对2006年至2013年间诊断出的n = 1945例CRC患者队列的单中心、双向、观察性随访研究。将对n = 485例CRC患者子集的存活者进行HRQoL子研究,这些患者在诊断时的基线HRQoL数据已经可得。从队列中每位患者的访谈和临床记录中获得的信息已经存在于先前研究的计算机化数据库中。这些数据包括社会人口学特征、癌症家族史、合并症、感知症状、诊断时的肿瘤特征、治疗类型以及诊断和治疗延迟间隔。对于随访,将使用医院记录更新有关局部复发、转移发生、新肿瘤和死亡率的信息。长期存活者的HRQoL将使用欧洲癌症研究与治疗组织(EORTC)的QLQ-C30和QLQ-CR29问卷进行评估。将进行总体和特定生存分析(竞争风险模型)。将估计相对生存率并应用混合治愈模型。最后,将通过多变量回归模型分析HRQoL。
我们期望本研究的结果能帮助我们更准确地确定CRC的长期生存情况,识别长期CRC存活者的需求和临床状况,并可用于提出CRC患者随访的新护理模式。